DR. REDDY'S LABORATORIES LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,872 INR | +0.02% |
|
-6.18% | +1.28% |
ETFs positioned on Dr. Reddy's Laboratories Limited
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.02% | 6 M€ | +6.07% | - | |
| 0.33% | 1 M€ | +3.49% | - | |
| 0.33% | 3 M€ | -.--% | - | |
| 0.20% | 11 M€ | +7.26% | ||
| 0.12% | 2,867 M€ | +10.42% | - | |
| 0.12% | 454 M€ | +8.71% | - | |
| 0.12% | 153 M€ | +7.16% | - | |
| 0.10% | 4 M€ | -4.41% | - | |
| 0.05% | 112 M€ | +5.58% | - | |
| 0.05% | 0 M€ | 0.00% | - | |
| 0.04% | 32 M€ | +8.84% | - | |
| 0.03% | 7 M€ | +5.65% | - | |
| 0.03% | 9 M€ | +31.85% | - | |
| 0.02% | 15 M€ | +17.61% | ||
| 0.01% | 34 M€ | +8.23% | - | |
| 0.01% | 45 M€ | 0.00% | - | |
| 0.01% | 391 M€ | +9.18% | - | |
| 0.01% | 39 M€ | +5.31% | - | |
| 0.01% | 306 M€ | +6.45% | - | |
| 0.01% | 34 M€ | +4.11% | - | |
| 0.01% | 105 M€ | +4.05% | - | |
| 0.01% | 17 M€ | +2.74% | - | |
| 0.01% | 54 M€ | +1.07% | - | |
| 0.01% | 14 M€ | -3.17% |
Dr. Reddy's Laboratories specializes in developing, producing, and selling pharmaceutical products. Net sales break down by activity as follows:
- sales of generic medications (79.9%): brand-name or generic prescription medications and OTC medicines;
- sales of active ingredients (15.7%). The group also supplies customized pharmaceutical services;
- other (4.4%): sales of generic biopharmaceutical products, development of molecular agents, etc.
Net sales are distributed geographically as follows: India (18.8%), the United States (45%), Russia (9.9%) and other (26.3%).
Sector
Pharmaceuticals
Calendar
2024-07-23
- Q1 2025 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
HOLD
Number of Analysts
35
Last Close Price
5,872
INR
Average target price
6,101
INR
Spread / Average Target
+3.89%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +1.28% | 11.71B | |
| +31.37% | 588B | |
| -2.79% | 364B | |
| +20.48% | 326B | |
| +5.49% | 285B | |
| +14.83% | 239B | |
| +9.93% | 210B | |
| -6.95% | 200B | |
| +10.82% | 167B | |
| +0.14% | 161B |
- Stock Market
- Equities
- DRREDDY Stock
- Funds and ETFs Dr. Reddy's Laboratories Limited
